Solid Tumor Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
- Malignant Solid Tumors
- +4 more
- Washington, District of Columbia
- +1 more
2022-04-07
Apr 7, 2022I
Recruiting
- Solid Tumor
- +2 more
- Sutton, Surrey, United KingdomRoyal Marsden Hospital NHS Foundation Trust
2022-03-31
Mar 31, 2022M
Completed
- Solid Tumor
- +2 more
- Boston, Massachusetts
- +3 more
2022-04-07
Apr 7, 2022N
Recruiting
- Metastatic Prostate Cancer
- +4 more
- M7824
- +4 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022N
Recruiting
- Cancer
- +3 more
- Bintrafusp Alfa
- +2 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022N
Recruiting
- Sickle Cell Disease
- +3 more
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022O
Recruiting
- Solid Tumor
- Cheongju-si, Korea, Republic of
- +7 more
2022-04-06
Apr 6, 2022D
Recruiting
- Solid Tumor
- Hematologic Malignancy
- Chicago, Illinois
- +2 more
2022-04-06
Apr 6, 2022E
3
Recruiting
- Solid Tumor
- KN035
- Beijing, Beijing, ChinaPeking University Cancer Hospital, Peking University
2022-04-05
Apr 5, 2022M
Recruiting
- Mesothelioma
- +5 more
- Nashville, Tennessee
- +2 more
2022-04-06
Apr 6, 2022M
Not yet recruiting
- Solid Tumor
- Re-irradiation
- (no location specified)
2022-03-28
Mar 28, 2022K
H
Recruiting
- Non Small Cell Lung Cancer
- +6 more
- Encinitas, California
- +5 more
2022-04-04
Apr 4, 2022M
Recruiting
- Advanced Cancer
- +9 more
- Birmingham, Alabama
- +6 more
2022-04-04
Apr 4, 2022I
Recruiting
- Solid Tumor
- Relaxation with music listening and medical hypnosis during radiotherapy treatment:
- Relaxation with music listening during radiotherapy treatment:
- Toulouse, FranceInstitut Universitaire du Cancer de Toulouse - Oncopole
2022-03-28
Mar 28, 2022C
Recruiting
- Solid Tumor
- Los Angeles, California
- +9 more
2022-03-25
Mar 25, 2022V
Not yet recruiting
- Solid Tumor
- (no location specified)
2022-03-22
Mar 22, 2022I
Active, not recruiting
- Bladder Cancer
- +3 more
- IPI-549 (eganelisib)
- +2 more
- Fort Wayne, Indiana
- +28 more
2022-04-01
Apr 1, 2022F
Completed
- Cancer
- +8 more
- Abbeville, France
- +147 more
2022-03-23
Mar 23, 2022W
Recruiting
- Solid Tumor
- Melanoma
- OH2 injection
- Keytruda
- Beijing, Beijing, ChinaPeking University Cancer Hospital
2022-04-01
Apr 1, 2022D
Terminated
- Solid Tumor
- Debio 1347
- Scottsdale, Arizona
- +104 more
2022-03-30
Mar 30, 2022P
Enrolling by invitation
- Lymphoma, B-Cell
- +4 more
- Burbank, California
- +90 more
2022-03-31
Mar 31, 2022C
Not yet recruiting
- Solid Tumor
- Hematological Malignancies
- NiCE
- Routine PPC
- Shanghai, Minhang, ChinaChildren's Hospital of Fudan University
2022-03-29
Mar 29, 2022M
Recruiting
- Solid Tumor
- +3 more
- Basking Ridge, New Jersey
- +4 more
2022-03-31
Mar 31, 2022